Delivery Order SPE2DB22D9367-SPE2DB24FSV06
- Not listed
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $5,678.70 by the Defense Logistics Agency Troop Support Medical to provide NUCALA 100 MG/ML auto-injectors. This delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency, which has a potential value of up to $5 million through December 2025 to supply atropine, Surgilube lubricant, heparin, Narcan nasal spray, intravenous saline, midazolin...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $7,571.60 by the Defense Logistics Agency Troop Support Medical to provide NUCALA 100 MG/ML auto-injectors. This delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency, which has a potential value of up to $5 million through December 2025 to supply atropine, Surgilube lubricant, heparin, Narcan nasal spray, intravenous saline, midazolin...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $22,714.80 by the Defense Logistics Agency Troop Support Medical to provide NUCALA 100 MG/ML auto-injectors. This delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency, which has a potential value of up to $5 million through December 2025 to supply atropine, Surgilube lubricant, heparin, Narcan nasal spray, intravenous saline, midazolin...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $11,357.40 under an indefinite delivery contract with the Defense Logistics Agency to supply NUCALA 100 MG/ML auto-injectors. The delivery order has a completion date of November 7, 2023. As a woman-owned small business, DMS Pharmaceutical Group regularly obtains delivery orders to provide pharmaceutical and medical supply support to military treatment facilities for the Defense Logistics Agency under various...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $9,464.50 from the Defense Logistics Agency Troop Support Medical to provide NUCALA 100 MG/ML auto-injectors. This delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency, which has a potential value of up to $5 million through December 2025. Under the indefinite delivery contract, DMS Pharmaceutical Group supplies pharmaceutical items and...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $13,250.30 under an indefinite delivery contract with the Defense Logistics Agency to supply NUCALA 100 MG/ML auto-injectors. As a woman-owned small business, DMS Pharmaceutical Group will provide the pharmaceutical items to DLA Troop Support Medical facilities. The delivery order has a completion date of December 15, 2023. DMS Pharmaceutical Group currently supplies various medical products to the Defense...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $3,785.80 under an indefinite delivery contract with the Defense Logistics Agency to supply NUCALA 100 MG/ML auto-injectors. As a woman-owned small business, DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides prescription drugs and medical supplies to support military treatment facilities worldwide. The delivery order is for provision of the specified pharmaceutical item to DLA Troop...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $3,785.80 under an indefinite delivery contract with the Defense Logistics Agency to supply NUCALA 100 MG/ML auto-injectors. As a woman-owned small business, DMS Pharmaceutical Group provides pharmaceutical and medical supplies to support military treatment facilities worldwide. The delivery order was awarded on December 4, 2023 and requires completion by December 5, 2023. DMS Pharmaceutical Group currently...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency for $5,678.70. The order is for the supply of NUCALA 100 MG/ML auto-injectors to fulfill requirements at Defense Logistics Agency Troop Support Medical facilities. DMS Pharmaceutical Group holds an indefinite delivery contract with the Defense Logistics Agency, valued at up to $5 million through December 2025, to provide pharmaceuticals and...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency for $1,892.90. The order is for the supply of 4562879115 NUCALA 100 MG/ML auto-injectors to fulfill requirements at Defense Logistics Agency Troop Support Medical facilities. DMS Pharmaceutical Group holds an indefinite delivery contract with the Defense Logistics Agency, valued at up to $5 million through December 2025, to provide...
- SPE2DB22D9367Indefinite Delivery Contract
- SPE2DB22D9367-SPE2DB24FSV06Delivery Order
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $3,785.80 under an indefinite delivery contract with the Defense Logistics Agency to supply NUCALA 100 MG/ML auto-injectors. As a woman-owned small business, DMS Pharmaceutical Group provides pharmaceuticals and medical supplies to support military treatment facilities worldwide. The delivery order is for provision of the specified pharmaceutical item to DLA Troop Support Medical locations, exercising options under an existing IDV held by DMS Pharmaceutical Group. The IDV, valued at up to $5 million through December 2025, enables delivery orders for atropine, Surgilube lubricant, heparin, Narcan nasal spray, intravenous saline, midazolam hydrochloride and other medical supplies on a firm fixed price basis to fulfill needs at military treatment centers supported by the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 11/16/23 |